etiocholanolone has been researched along with digoxin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, G; Carminati, P; De Munari, S; Ferrari, P; Gagnol, RJ; Loi, MF; Mattera, GG; Melloni, P; Micheletti, R; Rocchetti, M; Schiavone, A; Zaza, A | 1 |
| Besana, A; Ferrari, P; Micheletti, R; Mostacciuolo, G; Rocchetti, M; Zaza, A | 1 |
| Besana, A; Ferrari, P; Jona, I; Micheletti, R; Mostacciuolo, G; Rocchetti, M; Sarkozi, S; Szegedi, C; Zaza, A | 1 |
| Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V | 1 |
| Campia, U; Gheorghiade, M; Nodari, S | 1 |
| Alemanni, M; Re, D; Rocchetti, M; Zaza, A | 1 |
1 review(s) available for etiocholanolone and digoxin
| Article | Year |
|---|---|
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents | 2009 |
5 other study(ies) available for etiocholanolone and digoxin
| Article | Year |
|---|---|
Pharmacological profile of the novel inotropic agent (E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride (PST2744).
Topics: Animals; Cardiotonic Agents; Digoxin; Dogs; Dose-Response Relationship, Drug; Etiocholanolone; Guinea Pigs; Heart Atria; In Vitro Techniques; Myocardial Contraction; Myocardial Infarction; Myocardium; Physical Exertion; Radioligand Assay; Sodium-Potassium-Exchanging ATPase; Ventricular Function, Left | 2002 |
Diverse toxicity associated with cardiac Na+/K+ pump inhibition: evaluation of electrophysiological mechanisms.
Topics: Animals; Arrhythmias, Cardiac; Calcium Channels; Cardiotonic Agents; Cell Separation; Digoxin; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Etiocholanolone; Female; Guinea Pigs; Heart Diseases; In Vitro Techniques; Membrane Potentials; Myocardium; Potassium Channels, Inwardly Rectifying; Sodium-Potassium-Exchanging ATPase | 2003 |
Modulation of sarcoplasmic reticulum function by Na+/K+ pump inhibitors with different toxicity: digoxin and PST2744 [(E,Z)-3-((2-aminoethoxy)imino)androstane-6,17-dione hydrochloride].
Topics: Animals; Calcium; Calcium-Transporting ATPases; Digoxin; Electrophysiology; Enzyme Inhibitors; Etiocholanolone; Guinea Pigs; Heart Ventricles; In Vitro Techniques; Membrane Potentials; Myocardial Contraction; Myocytes, Cardiac; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Potassium-Exchanging ATPase | 2005 |
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea | 2010 |
Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity.
Topics: Animals; Calcium; Cardiotonic Agents; Cells, Cultured; Digoxin; Electrophysiology; Etiocholanolone; Female; Mice; Mice, Inbred C57BL; Sarcoplasmic Reticulum; Sodium-Potassium-Exchanging ATPase | 2011 |